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Abstract:
Better managing diabetes has become a global priority, especially given the exponential increase in the number of
diabetes patients and the financial implications of treating this silent epidemic. In this paper, we focus on how it might
be possible to use a mobile technology solution to support and enable superior diabetes monitoring and management.
To test this solution, we examined the context of gestational diabetes and adopted a non-blinded randomized control
trial with two-arm cross over applied to a private hospital in Victoria, Australia. Further, we use an accountable care
system as the theoretical lens and, from this, develop a conceptual framework to bridge evidence-based management
with technologies. Theoretically, we unpack McCleallan, McKethan, Lewis, Roski, and Fisher’s (2010) study with our
conceptual framework that comprises providers for information (evidence-based management) and technology
(smartphone). We enhance Muhlestein, Croshaw, Merrill, Pena, and James’ (2013) accountable care paradigm with
three concepts: 1) quality of life, 2) evidence-based management, and 3) affordable care. From the perspective of
practice, far-reaching implications have arisen particularly for hospital management pertaining to the cost and quality
of care issues. In particular, it appears that adapting mobile technology solutions such as smartphones to support
various aspects of care and patient-clinician interactions is a prudent choice to minimize costs and yet provide highquality care.
Keywords: Evidence-based Decision Making, Accountable Care, Management of Gestational Diabetes Mellitus
(GDM), Quasi-experimental Approach.
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Using Smartphones for Accountable Care and Evidence-based Decision Making in Managing Gestational
Diabetes: An Australian Case Study

Introduction

Globally, diabetes is one of the leading chronic diseases: it is increases at such an alarming rate that the
WHO has labeled it a silent epidemic (World Health Organization, n.d.; AIHW, 2007). Australia reflects this
global trend with approximately 1 million Australians currently diagnosed with diabetes (Baker IDI, 2012).
This alarming phenomenon serves to motivate the present research. Specifically, we focus on using a
mobile technology solution to provide superior management and monitoring in the context of gestational
diabetes and model this scenario in terms of accountable care and evidence-based decision making.
Traditionally, healthcare delivery has been designed to treat patients at the point of care with less focus on
being proactive in supporting preventative measures that keep people healthy and away from the hospital
(LeRouge & Wickramasinghe, 2013) due primarily to the fact that, historically, most key diseases have
been infectious in composition (U.S. Department of State, 2015). However, we are now witnessing a
significant rise in chronic diseases (Geisler & Wickramasinghe, 2009). Contemporaneous with this are two
other key trends; namely, the rapid growth of technology solutions for healthcare (Wickramasinghe &
Schaffer, 2010) and an increasing focus on the accountability of care (Morse, 2010).
Accountable care aims to improve quality and lower healthcare costs by proactively keeping people
healthy and away from the hospital (Morse, 2010). This view of healthcare is one of the most significant
drivers of the present U.S. health reform. Further, it has supported the launch of pilot projects to test the
concept, examine its sustainability, and explore how the model might look and be assessed for its
potential (McClellan et al., 2010). Australia shares this goal and, currently, Australian healthcare has a
vision to provide a new paradigm of healthcare based on integrated, person-allied, distributed, and
coordinated care delivery (Blatt, Dishman, & Wilson, n.d.). However, this concept is challenging,
especially when applied into solo and small-group practices, given the set up cost required such as IT
(information technology) investment and quality improvement training for staff (Shields, Patel, Manning, &
Sacks, 2011). In view of this critical challenge, low-cost technology solutions that require little
infrastructure are preferable. Hence, we examine the possibility of using a mobile Web-based reporting
system that leverages existing available resources (e.g., smartphones and cloud systems) and, thus,
requires minimal IT cost and/or user training. Thus, we use a pervasive mobile technology solution to
address a current dilemma; namely, the support of gestational diabetes through improved accountable
patient care.
Primarily, we examine the role a pervasive mobile solution might play in supporting the accountable care
paradigm. To do so we specifically focus on the use of a pervasive mobile technology solution to support
superior management and monitoring in the context of the chronic disease diabetes. Specifically, we
investigate:
RQ: How can mobile devices such as smartphones assist in preventing and/or reducing the
impact of gestational diabetes (GDM)?
GDM is a type of diabetes that occurs during pregnancy and is defined as glucose intolerance that is first
detected during pregnancy and affects about 5-8 percent of pregnant women (Siri & Thomas, 1999). Key
considerations with gestational diabetes include the health of both the mother and the unborn child since,
without proper care, there is a known increased risk for type 2 diabetes for the mother in the future and
the child may also be at risk of developing type 1 or 2 diabetes later in life (Diabetes Australia, 2008,
2012). Our study focuses on GDM in adult women. Given that this age group is not only technology savvy
but also in general represents a group in the population that frequently uses smartphones, we believe this
is a prudent domain to focus our investigations to successfully address the study objective.
This study then serves to investigate the possibility for an innovative, easy-to-use, and cost effective
solution to address a growing and serious health concern. It is one of the first studies to investigate the
application of a pervasive mobile technologies to a major health problem in Australia. The proposed
solution has the potential to have far-reaching implications to potentially all types of chronic diseases
generally and specifically benefits the respective healthcare organizations that we involve in this study and
more especially their patients by enabling them to have exclusive access to what has been described as a
leading-edge technology solution for supporting superior care in managing chronic diseases.
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Managing diabetes using information technologies is a relatively recent priority in the healthcare domain
and the focus on diabetes has increased as this chronic disease has become one of the most prevalent
and exponentially increasing diseases around the world (LeRouge & Wickramasinghe, 2013). Further, the
cost of managing patients with diabetes is also considerable, largely due to the fact that, as a chronic
disease, there is no foreseeable cure and that diabetes can lead to many complex co-morbidities that also
require treatment (Troshani, Goldberg, & Wickramasinghe, 2012). Diabetes Australia (2012) has
estimated that treating patients with diabetes costs the country over AUD$14.6 billion each year and that
complications can increase this cost even further by at least AUD$9,645 per year per individual. Because
diabetes is a chronic disease, there is by definition no cure; patients look forward to a reduced life quality
for the rest of their life and to the real possibility of developing many of the unpleasant complications that
can arise with long-term diabetes (Diabetes Australia, 2012). At the same time, from a healthcare
management perspective, this scenario translates into significant costs for the respective health systems
in Australia to bear and indirect societal costs that represent productivity losses for both patients and their
careers (DiabCost Australia, 2002; Diabetes Australia, 2013). For this reason, an effective management
system that enables early detection and supports pro-active management of diabetes is essential (Geisler
& Wickramasinghe, 2009; AIHW, 2008).

2.1

Management of Diabetes

Generally, managing diabetes is based on a mixture of self-management protocols linked with the support
of a dedicated medical care team (Victorian Government, 2007). An essential element of selfmanagement relies on regular testing of blood glucose by using a glucometer or blood glucose monitor to
enable better assessment and control of blood glucose and, thus, prevent further complications. Blood
glucose tests are usually completed before meals, but, depending on how the diabetes is managed (diet
only, insulin injections, insulin pumps), numerous blood tests may be conducted each day. Current blood
glucose monitors can store individual glucose readings as a record over a period of time. More recently,
we have seen monitors incorporate analysis tools for tracking trends based on these readings (e.g., Aviva
Expert: https://www.accu-chek.co.uk/gb/products/metersystems/avivaexpert.html). Mobile apps are also
used as diaries or records of these daily glucose readings (e.g., Glucose Buddy:
https://itunes.apple.com/us/app/glucose-buddy-diabetes-helper/id294754639?mt=8). Continuous glucose
monitoring systems continue to develop and provide the diabetic with trend information on their daily
glucose patterns. Each of these approaches provides information that the diabetic needs to assess and
interpret as part of their regular managing their diabetes. This information is complemented by other
clinical tests such as the HbA1c, which measures longer-term glucose management (d’Emden et al.,
2012). Such tests are managed by the clinical care team, and, generally, the daily self-recorded glucose
information and the longer term clinical information is compared only during patient-clinician
appointments. Glucose monitors provide increasingly more information and analysis tools to support
individuals in self-managing their diabetes. However, feedback on this information by members of the
clinical team tends to be limited because most of the self-managed information is “offline” to the clinical
team or made available only in batch uploading. We suggest that using mobile communication to make
self-managed readings accessible in real time to a clinical team may assist in managing and controlling
diabetes

2.1.1

Gestational Diabetes Mellitus

Gestational Diabetes Mellitus (GDM) requires tight control of blood sugar levels, with a preferred range of
readings between 4-6 mmol/L (Hoffman, Nolan, Wilson, Oats, & Simmons, 1998; Siri & Thomas, 1999).
GDM is managed over a short period of time (typically only the last eight weeks of the pregnancy). Thus, a
tighter control of sugar levels is required in the GDM context because of the impact of high blood sugar to
not only the mother but also the developing foetus; poor control of sugars can lead to serious and farreaching unpleasant consequences for the newborn baby. The need for such control draws into question
the information that a diabetic may need when self-managing their condition.
Despite all the existing methods and technologies in the market, we need to maximize the benefits of
digital convergence by providing a cost-effective solution that is convenient to both patients and clinicians,
supports patient self-empowerment, and is minimally disruptive to patients’ lifestyle. Hence, INET
International developed a pervasive technology solution to facilitate patient empowerment with their
diabetic care. Succinctly, the solution uses pervasive mobile technology to transfer critical information
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between patient and providers so that superior monitoring may ensue. This solution has proved
successful in Canada and the US (Wickramasinghe & Goldberg, 2004, 2007). We contend that a
pervasive technology solution can not only enable ubiquitous (anytime, anywhere, anyplace) monitoring
GDM patients but also provide them with accountable care service.

2.2

Accountable Care System

An accountable care system (ACS) refers to an entity that implements organized processes to improve
and control the quality of care and cost and that, more importantly, holds the providers accountable for the
results (Shortell & Casalino, 2008). Specifically, the term “system” refers to the care that must be
established and delivered by healthcare providers (e.g., physicians, clinicians, nurses) and settings (e.g.,
hospital and nursing homes) over time with accountability to ensure quality care with reduced costs
(Shortell & Casalino, 2008; McClellan et al., 2010; Shields et al., 2011).
An examination of the literature suggests that many studies look into the importance (Shortell & Casalino,
2008), application (Shields et al., 2011), and execution of the accountable care system (McClellan et al.,
2010; Lewis, McClurg, Smith, Fisher, & Bynum, 2013), ethical challenges for ACOs (DeCamp et al.,
2014), and its quality performance standard (Berwick, 2011). However, issues such as how quality of care
is being defined and measured remain vast and unclear (Dentzer, 2013). More importantly, doctors’
decisions are not always based on evidence and, in fact, only 55 percent adhere to evidence-based care
(Asch, Kerr, & Keesey, 2006).
The pressure to provide evidence-based care has significantly impacted the medical sector over the past
decade (Wickramasinghe & Schaffer, 2010). Much research is being conducted to understand what it is,
how it will impact medical practices, what its challenges are, and how it could benefit people,
organizations and society (Pfeffer & Sutton, 2006; Shortell & Casalino, 2008; Wickramasinghe & Schaffer,
2010). Traditionally, evidence-based management is complimented with online services and technology
(Jadad, Haynes, Hunt, & Browman, 2000). In this context, quality of care and cost was often being
compromised (Jadad et al., 2000). In this study, to overcome such an issue in achieving affordable care,
we need a bridge between evidence-based care and technology that can then support the paradigm of
accountable care. In view of this idea, we propose a conceptual model (Figure 1) to explore our research
question. Accountable care “may involve a variety of provider configurations, ranging from integrated
delivery systems and primary care medical groups to hospital-based systems and virtual networks of
physicians such as independent practice associations” (McClellan et al., 2010, p. 983). Managing GDM
calls on a range of such provider configurations including formal patient/health provider meetings and selftesting and the management of glucose readings. In this research, we examine the use of virtual network
and communication through mobile and Web-based technology as a means to support and enhance
patient care. In the framework of an accountable care system, such technology may allow increased
patient support and care through continuous monitoring and professional feedback but in a paradigm that
has minimal impact on delivery’s financial needs.

Information

Technology
Accountable care paradigm

Evidence-based
management





Measured Outcomes
Process-level
Care
Management
Aligned
Financial

Technology:
Smartphone,
Internet

Figure 1. Concept Model
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McClellan suggests that “clinical transformation is the linchpin of ACOs’ [accountable care organizations’]
success” (McClellan, et al., 2013 p. 988) and that such a transformation “requires effective investment in
infrastructure, process and organizational redesign, and other clinical activities to achieve delivery reforms
that can actually produce needed improvements in care (for example, enhanced preventive care, better
care transitions, and chronic disease management)” (McClellan et al., 2013, p. 989). McClellan sees that
organizations that adopt an accountable care framework need to extend their IT healthcare systems so
that they can manage more detailed clinical data as a means to improve healthcare. Researchers have
developed several frameworks to support accountable care systems, including models for assigning
patients to ACO using prospective and performance year methods (Lewis et al., 2013) and an
accountable care paradigm to support implementation (Muhlestein et al., 2013).
The accountable care paradigm that Muhlestein et al. (2013) propose defines the movement in terms of
structural requirements, core processes, and expected outcomes and presents these items as three tiers
or levels: (1) “outcome measurements”, (2) “process-level care management”, and (3) “aligned financial
structures”. It is a reasonable framework on which we build our paper because we suggest that, to further
develop this accountable care paradigm, quality of care should also be a focus and should include (1)
quality of life, (2) evidence-based management, and (3) affordable care.
The first level of the accountable care paradigm is about accountable care outcome measurements
(Muhlestein et al., 2013). It comprises three criteria: (1) improving the individual experience of care, (2)
improving the population health, and (3) reducing the cost of healthcare for populations (Muhlestein et al.,
2013). With these criteria, we believe that healthcare delivery can further improve individuals’ quality of
life. Usually, patients have little or no control over the cost of their care and almost no information
available to them regarding the cost or quality of care delivered by their provider(s) or care giver(s) (Bozic,
2013). For this reason, we believe that, for some health issues, the ability to measure accountable care
outcomes requires the care providers and givers avail patients with several treatment options that are
based on the service the patients receive and costs involved. This provides patients with options as to
how they can live a better-quality life.
Process level care management is the second level of the accountable care paradigm (Muhlestein et al.,
2013). This level comprises three criteria: (1) overseeing the provision of clinical care, (2) adopting an
administrative infrastructure to coordinate the provision of care across the continuum of health services,
and (3) investing in and learning to use appropriate information technology to manage the population’s
health. To enhance the quality process level of care management, we suggest including the concept of
evidence-based management. Especially with the empowerment from technologies, many physicians
today are able to capitalize on rich online information to build expert communities for knowledge and bestquality evidence and to share information with care givers and patience directly. To better amalgamate
evidence-based management into process level care management, we incorporated Rousseau’s (2013)
suggestion of “managing user expectation” through providing models of evidence-based practice that
promote the active use of evidence and build collaboration among all users. In this study, users include
physicians, nurses, and pregnant mothers.
The last level of accountable care paradigm is about aligning financial structures (Muhlestein et al.,
2013). Specifically, it entails: (1) bearing financial risk for the measured health of a population, and (2)
aligning financial and professional incentives to encourage the production of high-quality health outcomes.
Since these two criteria concern a wider research scope that includes revising government policy and
partnership between health plans and providers, we leave this section for future research. However, what
is more relevant here is to incorporate affordable care by providing choices in finding plans that are costeffective and appropriate to consumer needs. For example, using a smartphone approach may be a
cheap option for patients who require regular health monitoring to record and communicate with health
practitioners, which may become evident if compared to other more dedicated or sophisticated technology
that usually comes at a higher cost.
As we suggest above, Muhlestein et al.’s (2013) model can act as a framework for examining how
technology can support evidence-based care and reinforce McClellan et al.’s (2002) call for “clinical
transformation”. In this paper, the change agent we investigate is the addition of real-time glucose
feedback for GDM patients. The technology intervention bridges current diabetic practice of self-glucose
monitoring and “batched” clinical feedback from patient/clinician visits by providing real-time
communication between patients and their clinical team. The need for GDM patients to maintain tight
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control of glucose levels can be supported by clinical feedback and intervention on an ongoing basis. In a
similar way that continuous glucose monitoring can provide regular information to help some diabetic
patients to monitor glucose trends, the mobile solution we pose in this paper provides a communication
channel for a clinical team to monitor the glucose control needs of a GDM patient. While it is not a
continuous glucose reading, it is a framework for ongoing communication with the clinical team. This
communication has the potential to improve patient care via using existing technology (smartphone and
current glucose monitors) and a cloud-based information management platform and, thus, meet
Muhlestein et al.’s (2013) framework levels.

3

Methodology

As part of our ongoing effort to understand changes occurring in the Australian healthcare system, we
have been identifying and tracking healthcare organizations that appear to practice at least some aspects
of accountable care from the Australian perspective. As such, we identified AusHospital (name
anonymized) because we believe that it showed unique characteristics with regard to accountable care. In
fact, the hospital’s medical staff initiated and appreciated many of its aspects.
On selecting the specific hospital to evaluate, we adopted a user-centered design approach to develop a
unique mobile solution to support GDM patients to self-manage their condition. Specifically, we adapted
the Web-based mobile solution developed over several years by INET International (Goldberg, 2002;
Wickramasinghe & Goldberg, 2008; Wickramasinghe, Troshani, & Goldberg, 2010). In particular, the
solution works as follows (Figure 2): after the patient has taken their blood sugar reading using a
glucometer, they enter the reading into a Web-based form designed for smartphones. The submitted
reading is then accessible to the designated clinician who can then review the readings in conjunction with
all other relevant medical data to provide immediate feedback and recommendations to the patient. Such
recommendations pertain to food intake, exercise, and/or insulin titration. Figure 2 illustrates the charted
record of patient readings that the clinician can access. The chart displays the four readings normally
taken for GDM patients (i.e., before breakfast, two hours after breakfast, two hours after lunch, and two
hours after dinner). The mobile interface also allows patients to write messages about their food and
exercise consumption, and the clinician can review this information and provide additional feedback to the
patient. All of this communication is managed through the mobile solution and provides a health model
that can immediately support patients remotely located from the hospital setting.

Figure 2. The Solution in a Nutshell

We adopted this specific mobile solution because it is independent of a specific mobile platform (i.e., it is
pervasive in nature); instead, it uses the phone’s (and, if needed, computer’s) Web browser for data input.
The solution is also independent of the device used for glucose testing. While future developments could
adopt mobile app-based or glucose device-driven interfaces for inputting data, the current platform helps
patients more easily adopt the solution because it is not tied to a single glucose of mobile technology. This
pervasive quality makes the solution particularly consistent to an accountable care paradigm.
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Once we correctly calibrated the solution to the local environment at AusHospital, we then trialed it using a
two-arm, two-period cross-over clinical trial strategy after we obtained all necessary ethics clearances
(Rigby, 2003; Senn, 2002) over 10-week duration. Research studies have shown (Rugby, 2003; Senn,
2002) that, when testing the usability and fidelity of a technology solution for a healthcare context, a twoperiod cross-over study research design is prudent because it enables all participants to have experience
with and without the technology solution. The two arms (standard care and technology with standard care)
are required so that it is possible to have one group start with the standard care and then progress to the
technology with standard care solution and the other group start with the standard care with technology
solution and then change to the standard care solution. Such an approach enables an internal validity
check (Rugby, 2002; Senn, 2002). We chose the 10-week timeframe since most patients are diagnosed
with GDM when they are around 26 weeks’ pregnant; as such, the 10-week timeframe then enabled us to
get a five-week timeframe for each cross over before the due date. Finally, the ethics committees at both
the hospital and our university and the obstetricians involved cleared our study design.
In Australia, pregnancy studies require the highest level of ethics clearance by law. The ethics clearance
approved 10 GDM patients to be recruited into the study on the approval of their consulting obstetrician.
We deemed 10 to be sufficient to establish proof of concept while noting it would not provide statistical
significant results at this point. However, we thought that, once proof of concept had been established, it
would be possible to embark on a large-scale trial. Once the patients were identified as appropriate and
“medically safe” to participate in the study, we then randomly allocated them to one of two trial groups—
the study’s technology arm or standard care arm. Patients in the standard care arm followed recognized
current practices for treating patients with GDM at AusHospital, which primarily focused on patients
reporting a batch of glucose reading at the physical time of their meeting with medical practitioners.
Patients in the technology arm of the study, in addition to following the recognized practices in the
standard care arm, also used the smartphone solution. In this way, we could capture the benefits of the
technology solution over the existing standard care protocols. We briefed both groups of patients on
critical factors for GDM care and management and gave them a questionnaire to complete before they
began monitoring and managing their GDM. After five weeks, cross over took place, at which time we
introduced the standard care arm to the technology and the initial technology arm to the standard care
protocols. At this time, we provided participants with a cross-over point questionnaire. At the end of the
10-week period, we debriefed all patients and asked them to complete a final questionnaire. In addition,
we asked all clinicians including obstetricians, diabetic nurses, and endocrinologists to complete a preand post-study questionnaire based on their observations and interactions. Some of the patients required
insulin, and we programmed the mobile solution to support insulin titration and advise patients regarding
their specific prescribed insulin. This trial took two years to complete given that we recruited patients as
they presented to the clinic and we screened/approved them to be suitable for the study (i.e., it was not
possible to at the same time have all 10 pregnant patients with GDM to commence the trial at the same
time).

4

Results and Discussion

All patients preferred the technology solution irrespective of whether they started in the study’s technology
arm or standard care arm. Further, using the smartphone solution, clinicians and patients could more
quickly and easily recognize out-of-range blood sugar readings. Patients who started with the mobile
solution found it difficult to go to the standard care solution. Although the sample size (10 patients) was
too small for statistical significance, we not only established proof of concept but also demonstrated the
benefits of a real-time smartphone solution to help GDM patients self-manage and monitor their condition.
The clinical care team (obstetricians, diabetic educators and endocrinologists) preferred the technology
solution over the standard care approach: they noted that it enabled them to better keep track of patients
and quickly recognize if there were problems developing and/or be able to reassure patients that all was
okay. Both patient and clinical users had further suggestions at the study’s conclusion for further additions
to the technology solution’s features and capabilities. Clearly, the small sample size is a limitation;
however, given the very stringent ethics requirements concerning pregnancy-type studies, we could only
run a small pilot initially to establish proof of concept. Armed with our positive results, we plan to embark
on a larger study.
Based on the research method we used, we mapped the collected results with the affordable care
paradigm. We found that the smartphone solution supports the affordable care paradigm at multiple
levels.
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The first level of the accountable care outcome measurements is based on improved individual
experience of care and improved population health (all sufferers of GDM in this context) on maximizing
outcomes and control costs. For example, one of the patients noted that “having the mobile phone to
monitor my sugar helps me to plan my day and eating and stick to this plan” . In addition, we noted that
reductions in healthcare delivery cost include less face-to-face consultation required with a similarquality (and, according to some of the patients, better) outcome. Thus, with pervasive technology, patients
can reduce their associated costs such as their time and traveling costs for their weekly consultation,
increase their accessibility to their doctors and caregivers’ advice at no extra cost 24 hours, seven days a
week, and have a better level of peace of mind, which is especially significant in pregnancy-related health
issues. These results address the issues of patients having no control over the cost of care and almost no
information available to them as in Bozic’s (2013) study. Thus, in our study, we show how, the Australian
GDM patients can benefit by having a better quality of care and enjoying better health for themselves and
their babies. Note, however, that, in this context, there was no additional risk to mother or baby in terms of
the pregnancy or quality of care because no reduction of visits to consult with the patient’s obstetrician
occurs and so the patients at all times felt very comfortable with the quality of care they received. What
was reduced were the additional medical visits. During pregnancy, these additional medical visits are time
consuming and a hassle for patients, while, for healthcare, they represent an extra cost burden. It appears
the pervasive technology solution offers the possibility for a best-of-both-worlds solution; namely, access
to the best care (which does not compromise the mother and her baby’s health) and convenience and
cost effectiveness.
Process level care management is the second level of the accountable care paradigm (Muhlestein et al.,
2013). At this level of care management, we see that using the digital convergence concept with
smartphones and a cloud system is not only cost effective but also user friendly for both patients and
clinicians. Based on our study, smartphone technology has demonstrated its ability to (1) provide quality
clinical care, (2) facilitate the adoption of an administrative infrastructure to better co-ordinate care, and (3)
low or essentially no learning curve because there is minimal need for the patient to invest in and learn
how to use the mobile solution to manage their health issue. Succinctly, the solution uses pervasive
mobile technology to transfer critical information between patient and providers so that they can better
monitor the patients’ health. Through this study, we contend that a pervasive technology solution that can
not only enable GDM patients (and their clinicians) to ubiquitously (anytime, anywhere, anyplace)
themselves but also provide them with process-level care management. To enhance the quality process
level of care management, we include the concept of evidence-based management in this study. Our
results show that the physicians were able to capitalize on the rich online information with Internet
connections to consult and diagnose patients with best-quality evidence. They were able to manage
patients’ expectation, provide models of evidence-based practice, and actively use evidence, which
subsequently built strong collaboration among all users (Rousseau, 2013).
Aligning financial structures (Muhlestein et al., 2013) is the third and last level of the accountable care
paradigm. In this study, we incorporated affordable care by using a smartphone app that offers a cheaper
and simpler option for patients who require regular health monitoring to record and communicate with their
health practitioners. This affordability of care becomes evident if compared to other more dedicated or
sophisticated technology that usually not only comes at a higher cost but also requires additional learning
curve to use it.
From the perspective of measured outcomes of accountable care, it appears that using smartphones as a
health monitoring and communication channel not only improved the patient experience but potentially
provided them with a better quality of life. That is, patients with pertinent information were able to receive
timely evidence-based medical feedback, understand the result, and take appropriate actions in
controlling their blood sugar level. On a large scale, such results will serve to improve the population’s
health in a way that helps prevent GDM and reduces the impact of the mother passing high levels of
glucose to her baby in utero. Further, with such control, there is evidence of smartphones’ direct potential
to reduce healthcare costs for key stakeholders such as patients, their careers, and healthcare
professionals.

5

Conclusion

Our research contributes to theory and practice in several ways. From the perspective of practice, this
study strongly suggests that using smartphones to support GDM self-management not only helps GDM
patients to better monitor and manage their condition in an affordable way with evidence-based
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management but also supports the accountable care paradigm. Moreover, patients suffering from GDM
can benefit by having a better quality of care and enjoying better health for themselves and their babies.
From a theoretical stand point, we unpack McCleallan et al.’s (2010) study with our conceptual framework
that includes providers for information (evidence-based management) and technology (smartphone),
which are jointly held accountable for a defined population in achieving measurable healthcare quality
improvements with reductions in healthcare spending. Further, we enhance Muhlestein et al.’s (2013)
accountable care paradigm with the three concepts of (1) quality of life, (2) evidence-based management,
and (3) affordable care, and we address the issue of control over the cost of care and information
accessibility, which Bozic’s (2013) does not address.
Finally, in terms of managerial contributions, the study uncovers far-reaching implications for hospital
management as they currently wrestle with the orthogonal dilemmas of controlling costs and providing
high-quality care and value to patients. In particular, it would appear that they should investigate the
possibility of adopting smartphones to support many aspects of care and patient-clinician interactions.
In closing, we note that this was a small pilot study and one of the first of its kind to be run in Australia to
investigate the potential of smartphones to support the affordable care paradigm in managing and
monitoring GDM. Clearly, we need more confirmatory research to generate statistically significant results
and investigate the wider issues including revising governmental policy and investigating the implications
for contractual arrangements between health plans, healthcare organizations, and providers. We plan to
investigate such things in future research.
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